Assessing disease extent in women with bulky or clinically evident metastatic cervical cancer: Yield of pretreatment studies

Keyphrases

• Extent of Disease 100%
• Examination under Anesthesia 100%
• Pelvic Examination 100%
• Metastatic Cervical Cancer 100%
• Cancer Yield 100%
• Chest X-ray 80%
• Computed Tomography 60%
• Excretory Urography 60%
• Proctoscopy 40%
• Malignancy 20%
• Positive Predictive Value 20%
• Negative Predictive Value 20%
• Cervical Cancer 20%
• Obstetrics 20%
• International Federations 20%
• Tumor Diameter 20%
• Sensitivity Specificity 20%
• Lymphadenopathy 20%
• Abdominopelvic Computed Tomography 20%
• Ureteral Obstruction 20%
• Cystoscopy 20%
• Accurate Staging 20%
• Bladder Biopsy 20%
• High Cost 20%
• Bladder Transitional Cell Carcinoma 20%
• Vaginal Diseases 20%
• Size Mismatch 20%
• Accurate Treatment 20%
• Ureteral Dilation 20%
• Pelvic Lymphadenopathy 20%
• Sidewall 20%
• Computed Tomography Urography 20%

Medicine and Dentistry

• Cervical Cancer 100%
• Pelvic Examination 100%
• Diseases 100%
• Computer Assisted Tomography 80%
• Thorax Radiography 80%
• Intravenous Urography 60%
• Lymphadenopathy 40%
• Rectoscopy 40%
• Health Care Cost 20%
• Neoplasm 20%
• Cancer 20%
• Obstetrics 20%
• Bladder 20%
• Pelvis 20%
• Sensitivity and Specificity 20%
• Gynecology 20%
• Ureter Obstruction 20%
• Cystoscopy 20%
• Transitional Cell Carcinoma 20%
• Bladder Biopsy 20%
• Vagina Disease 20%